Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
Communication network management system, method and program, and management computer
Power management implementation in an optical link
Method for mapping resource units
Switching element for a valve train of an internal combustion engine
Device and implantation system for electrical stimulation of biological systems
  Randomly Featured Patents
Increasing resid hydrotreating conversion
Image exposure system
Registration system paper path length compensation
Glass as sintering aid and open-pore molded body and method for manufacturing same
Method of making an apparatus containing a diaphragm
Parallel processing data transfer arrangements
Device for reading and writing and the teaching of literacy
Call transfer with automatic return
Debugging system for semiconductor integrated circuit
Variably-adjustable grill light and method of use thereof